A systematic review and economic model of the effectiveness and ...
A systematic review and economic model of the effectiveness and ...
A systematic review and economic model of the effectiveness and ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
TABLE 2 An overview <strong>of</strong> trials included in <strong>the</strong> <strong>review</strong> – <strong>and</strong> comparators<br />
Study<br />
Placebo/st. comm. care/attent. contr.<br />
Non-drug (+ placebo)<br />
MPH low dose<br />
MPH medium dose<br />
MPH high dose<br />
MPH low dose + non-drug<br />
MPH medium dose + non-drug<br />
MPH high dose + non-drug<br />
MPH-SR low dose<br />
MPH-SR medium dose<br />
MPH-SR high dose<br />
MPH-SR low dose + non-drug<br />
MPH-SR medium dose + non-drug<br />
MPH-SR high dose + non-drug<br />
MPH low dose + MPH-SR 20 mg<br />
MPH + thioridazine hydrochloride<br />
DEX low dose<br />
DEX medium dose<br />
DEX high dose<br />
DEX medium dose + non-drug<br />
DEX high dose + non-drug<br />
DEX-TR/ER<br />
DEX-SR + non-drug<br />
ATX L+M<br />
ATX H<br />
Caffeine<br />
Pemoline<br />
Pemoline + non-drug<br />
Imipramine<br />
Adderall<br />
Adderall + non-drug<br />
MAOI + diet<br />
GLA 500 mg + vitamin E<br />
Chlorpromazine<br />
Hydroxyzine<br />
Levoamphetamine<br />
Thioridazine hydrochloride<br />
Pindolol<br />
Age (years) IQ<br />
© Queen’s Printer <strong>and</strong> Controller <strong>of</strong> HMSO 2006. All rights reserved.<br />
Health Technology Assessment 2006; Vol. 10: No. 23<br />
5.0–15 NR × × ×<br />
4.6–12 NR × × ×<br />
5.0–12 NR × × ×<br />
6.0–12 NR × × ×<br />
5.0–13 105 × × ×<br />
12.0–17 104 × × × 2<br />
6.3–11.8 102 × × ×<br />
5.7–13.1 97 × × × ×<br />
13–15 93 × × × ×<br />
6.0–13 93 × × ×<br />
6.0–12 NR × × ×<br />
6.0–11 NR × × ×<br />
4.0–6 NR × × × ×<br />
6.0–16 104 × ×<br />
6.0–11 NR × 3 ×<br />
5.0–14.9 99 × ×<br />
6.0–12 106 × × ×<br />
6.0–10 NR × × ×<br />
5.0–9 NR × × ×<br />
2.4–17.2 NR × × ×<br />
6.9–11.5 114 × × × ×<br />
6.0–11 NR × ×<br />
6.0–12 NR × × × ×<br />
6.5–11 85 × × × ×<br />
5.0–15 NR × ×<br />
continued<br />
Ahmann, 199335 Arnold, 1976 36<br />
Arnold, 1978 37<br />
Arnold, 1989 38<br />
Barkley, 1990 39<br />
Barkley, 2000 40<br />
Brown, 1985 41<br />
Brown, 1986 42<br />
Brown, 1988 43<br />
Buitelaar, 1996 44<br />
Conners, 1972 45<br />
Conners, 1980 46<br />
Conrad, 1971 47<br />
Dopfner, 2003 48<br />
DuPaul, 1993 49<br />
Efron, 1997 50<br />
Elia, 1991 51<br />
Fine, 1993 52<br />
Firestone, 1986 53<br />
Fischer, 1991 54<br />
Fitzpatrick, 1992 55<br />
Gillberg, 1997 56<br />
Gittelman-Klein, 1976 57<br />
Greenberg, 1972 58<br />
Greenhill, 2002 59<br />
17